JW (Cayman) Therapeutics Co. Ltd JWCTF
0.20 USD 0.00 (+0.00%)
At close·Nov 2, 2026, 4:00 PM EST
0.20223 52-week range 0.4523
- YTD
- -43.82%
- 1 year
- -55.29%
Altman Z-Score
-10.00 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 4
P/E -1.9×
P/S 3.8×
P/B 1.9×
P/FCF -13.3×
EV/EBITDA -5.0×
EV/Sales 2.9×
FCF Yield -7.5%
Gross Margin 43.0%
Operating Margin -87.5%
Net Margin -195.8%
ROE -97.2%
ROIC -29.5%
ROA -54.8%
Revenue 74.7%
Operating Income 47.4%
EPS (diluted) 7.0%
Free Cash Flow 77.5%
Current Ratio 1.4×
Quick Ratio 1.3×
Debt / Equity 0.5×
Net Debt / EBITDA 1.5×
Interest Coverage -21.7×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31